# BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
> **ANDA217288** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2024-12-30
## Drug
- **FDA Application Number:** ANDA217288
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- **Generic name:** Brimonidine Tartrate
- **Active ingredients:** BRIMONIDINE TARTRATE; TIMOLOL MALEATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL
- **First approval:** 2024-12-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217288)
---
*AI Analytics · CC0 1.0*